Avecho Biotechnology Limited (ASX:AVE)

Avecho Biotechnology Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	73	33	8	11	28	28
Market Cap Growth	358.67%	317.27%	-28.57%	-59.76%	0.10%	-40.60%
Enterprise Value	68	27	3	8	24	23
Last Close Price	0.02	0.01	0.00	0.00	0.01	0.01

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Forward PE	-	19.60	19.60	19.60	19.60	19.60
PS Ratio	58.80	26.71	7.00	23.42	24.41	34.71
PB Ratio	46.66	21.20	2.42	1.74	11.37	6.07
P/TBV Ratio	46.66	21.20	2.42	1.74	11.49	6.21
P/FCF Ratio	65.98	29.97	-	-	-	-
P/OCF Ratio	65.98	29.97	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	55.04	21.96	2.85	17.81	21.69	28.84
EV/FCF Ratio	61.76	24.64	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.33	0.03	0.10	0.02
Debt / FCF Ratio	0.01	0.01	-	-	-	-
Net Debt / Equity Ratio	-2.98	-2.98	-0.40	-0.84	-0.50	-0.70
Net Debt / EBITDA Ratio	1.22	1.22	0.44	1.64	0.58	1.07
Net Debt / FCF Ratio	-4.21	-4.21	0.33	1.68	0.71	0.96
Asset Turnover	0.21	0.21	0.18	0.09	0.26	0.19
Inventory Turnover	4.80	4.80	3.93	2.07	1.12	1.93
Quick Ratio	9.68	9.68	2.70	7.83	2.97	6.31
Current Ratio	9.95	9.95	2.81	8.31	3.83	6.91
Return on Equity (ROE)	-182.91%	-182.91%	-64.72%	-78.08%	-67.30%	-95.01%
Return on Assets (ROA)	-40.85%	-40.85%	-31.11%	-40.10%	-33.99%	-49.50%
Return on Capital Employed (ROCE)	-61.80%	-61.80%	-93.30%	-52.80%	-89.80%	-74.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-6.07%	-13.36%	-39.40%	-30.98%	-8.50%	-12.40%
FCF Yield	1.52%	3.34%	-50.09%	-28.67%	-6.23%	-11.99%
Buyback Yield / Dilution	-3.08%	-3.08%	-39.73%	-23.41%	-1.97%	-13.27%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error